cefdinir (Omnicef)

Indications

• treatment of bacterial infections including: pneumonia, bronchitis, ear infections, sinusitis, pharyngitis, tonsillitis, & skin infections
• empiric treatment of fever of unknown origin

Dosage

• 300 mg PO BID

Capsules: 300 mg

Solution: 25 mg/mL

Dosage adjustment in renal failure

• eGFR < 30 mL/min 300 mg QD

Antimicrobial activity

• Streptococcus
  • Streptococcus pneumoniae
  • Streptococcus pyogenes
• Haemophilus influenzae
• Haemophilus parainfluenzae
• Moraxella catarrhalis
• Staphylococcus aureus

Adverse effects

• dyspepsia
• vomiting
• loss of appetite
• diarrhea
• headache
• dizziness
• fatigue
• rash
• hives
• swelling of the face, eyes, lips, tongue, arms, or legs
• difficulty breathing or swallowing
• vaginal infection

• drug adverse effects of cephalosporins

More general terms

• cephalosporin, 3rd generation

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=